Bayesian Capital Management, LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 286 filers reported holding HAEMONETICS CORP in Q2 2020. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2022$561,797
+114.4%
7,143
+101.6%
0.08%
+54.7%
Q3 2022$262,000
-46.1%
3,543
-54.0%
0.05%
-27.4%
Q1 2022$486,000
-2.8%
7,694
+2.6%
0.07%
-44.3%
Q2 2021$500,000
-2.0%
7,500
+31.6%
0.13%
+17.0%
Q2 2020$510,000
+16.2%
5,700
+29.5%
0.11%
+17.9%
Q1 2020$439,000
-50.4%
4,400
-42.9%
0.10%
-37.1%
Q4 2019$885,000
+100.7%
7,700
+120.0%
0.15%
+81.9%
Q3 2019$441,000
-39.3%
3,500
-51.8%
0.08%
-44.3%
Q4 2018$726,000
+45.5%
7,254
+66.6%
0.15%
+81.7%
Q3 2018$499,000
-62.0%
4,354
-70.3%
0.08%
-72.3%
Q2 2018$1,314,000
+99.7%
14,654
+62.8%
0.30%
+77.2%
Q1 2018$658,000
-10.8%
9,000
-29.1%
0.17%
+11.3%
Q4 2017$738,000
+83.1%
12,700
+26.7%
0.15%
+50.0%
Q4 2016$403,00010,0230.10%
Other shareholders
HAEMONETICS CORP shareholders Q2 2020
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders